Literature DB >> 21601107

Advances in cervical cancer treatment.

Levi Downs.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21601107     DOI： 10.1016/j.ygyno.2011.04.010

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.

Authors:  Alfredo A Molinolo; Christina Marsh; Mohamed El Dinali; Nitin Gangane; Kaitlin Jennison; Stephen Hewitt; Vyomesh Patel; Tanguy Y Seiwert; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2012-03-12       Impact factor: 12.531

2.  TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.

Authors:  Ana Coelho; Augusto Nogueira; Sílvia Soares; Joana Assis; Deolinda Pereira; Isabel Bravo; Raquel Catarino; Rui Medeiros
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

3.  Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil.

Authors:  Hillegonda Maria Dutilh Novaes; Alexander Itria; Gulnar Azevedo e Silva; Ana Marli Christovam Sartori; Cristina Helena Rama; Patrícia Coelho de Soárez
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.